What is CorMedix's accounts receivable?

CorMedix (CRMD) reported accounts receivable of $154.81M in Q1 2026.

How has CorMedix's accounts receivable changed year-over-year?

CorMedix's accounts receivable increased by 183.5% year-over-year, from $54.61M to $154.81M.

What is the long-term trend for CorMedix's accounts receivable?

Over 3 years (2020 to 2025), CorMedix's accounts receivable has grown at a 3608.6% compound annual growth rate (CAGR), from $3.36K to $171.23M.

What does accounts receivable mean?

Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.

CorMedix CRMD Accounts Receivable

Accounts Receivable at other companies

PfizerPFE

$12.59B+6.2%

Merck & Co.MRK

$12.21B+13.2%

Merit Medical SystemsMMSI

$206.45M+3.5%

ITG

Integer HoldingsITGR

$327.78M+18.7%

IAR

Integra LifeSciencesIART

$264.41M+4.7%

Emergent BiosolutionsEBS

$121.6M-40.3%

Other financials

Income statement

See full

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

See full

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

See full

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

See full

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

See full

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

See full

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CorMedix's accounts receivable?: CorMedix (CRMD) reported accounts receivable of $154.81M in Q1 2026.
How has CorMedix's accounts receivable changed year-over-year?: CorMedix's accounts receivable increased by 183.5% year-over-year, from $54.61M to $154.81M.
What is the long-term trend for CorMedix's accounts receivable?: Over 3 years (2020 to 2025), CorMedix's accounts receivable has grown at a 3608.6% compound annual growth rate (CAGR), from $3.36K to $171.23M.
What does accounts receivable mean?: Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.